A protocol for a controlled, phase II, multi-arm, parallel-group, superiority, six-month trial comparing the effectiveness of far-UVC (222 nm) in two experimental arms against standard care in preventing viral and bacterial infections in long-term care facilities
Dive into the research topics of 'A protocol for a controlled, phase II, multi-arm, parallel-group, superiority, six-month trial comparing the effectiveness of far-UVC (222 nm) in two experimental arms against standard care in preventing viral and bacterial infections in long-term care facilities'. Together they form a unique fingerprint.